NEW YORK

,

March 5, 2021

/PRNewswire/ —


Juan Monteverde


, founder and managing partner at

Monteverde & Associates PC

, a national securities firm rated

Top 50

in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in

New York City

, is investigating



Five Prime Therapeutics, Inc. (“FPRX” or “the Company”) (



FPRX



)

relating to its proposed acquisition by Amgen, Inc. Under the terms of the agreement, FPRX shareholders will receive

$38.00

in cash per share.

The investigation focuses on whether Five Prime Therapeutics, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process, and 2) whether the transaction is properly valued.

Click here for more information:

http://monteverdelaw.com/case/five-prime-therapeutics-inc



.


It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the

Top 50

in the 2018 and 2019 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by

Martindale

-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm’s recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court.

Emulex Corp. v. Varjabedian

, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own common stock in Five Prime Therapeutics, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our



website



or contact

Juan E. Monteverde, Esq.

either via e-mail at



[email protected]



or by telephone at (212) 971-1341.

Contact:


Juan E. Monteverde, Esq.


MONTEVERDE & ASSOCIATES PC


The Empire State Building


350 Fifth Ave. Suite 4405


New York, NY

10118


United States of America




[email protected]



Tel: (212) 971-1341

Attorney Advertising. (C) 2021 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (


www.monteverdelaw.com


).  Prior results do not guarantee a similar outcome with respect to any future matter.

View original content:

http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-five-prime-therapeutics-inc–fprx-301241790.html

SOURCE Monteverde & Associates PC